
Abbott shares drop over 17% in 2026, with 5-year investment losing value amid growth challenges.
Abbott Laboratories' stock fell 17.79% in 2026, declining from $125.29 to $103.00, underperforming the S&P 500's 1.16% gain. Despite a $21 billion acquisition of Exact Sciences and plans to spin off its nutrition business, Abbott's growth slowed due ...




